Repaglinide

Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM) .

135062-02-1

≥ 2 years

>98% (HPLC)

452.59

C27H36N2O4

Research use only, not for human use.

Potassium Channel| PPARγ

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-08518DL594 100 µL

Ask

HY-100740C-01 5 mg

Ask

HY-100740C-02 10 mM - 1 mL

Ask

HY-100740C-03 10 mg

Ask

HY-100740C-04 50 mg

Ask

HY-100740C-05 100 mg

Ask